support_agent

Your contact persons

CHEPLAPHARM Arzneimittel GmbH

View:
format_list_bulletedgrid_view

01/25/2024

CHEPLAPHARM strengthens oncology portfolio with the acquisition of Myocet® from Teva
Press releases
Read morechevron_right

01/18/2024

CHEPLAPHARM acquires Roaccutane® from Roche
Press releases
Read morechevron_right

12/27/2023

Sebastian Braun takes over CEO position at BBG and joins the Supervisory Board at CHEPLAPHARM
Press releases
Read morechevron_right

11/06/2023

CHEPLAPHARM opens presence in Tokyo
Press releases
Read morechevron_right

09/21/2023

CHEPLAPHARM succesfully places additional notes in a volume of €300m
Press releases
Read morechevron_right

09/19/2023

Announcement on Pricing
Investors Domain Press releases
Read morechevron_right

09/18/2023

Announcement on Offering
Investors Domain Press releases
Read morechevron_right

09/12/2023

CHEPLAPHARM opens Swiss subsidiary and wins Agnes Wasem as Managing Director
Press releases
Read morechevron_right

07/27/2023

CHEPLAPHARM successfully closes acquisition of Zyprexa® portfolio
Press releases
Read morechevron_right

04/28/2023

CHEPLAPHARM places notes in a volume of €750m in challenging market environment
Press releases
Read morechevron_right
Back to topexpand_less